Data · dataset · 2025
Cangrelor
Listed in Virginia Open Data Portal
Description
Kengreal (cangrelor) is an intravenous antiplatelet medication that works by inhibiting platelet aggregation to reduce the risk of blood clots during certain heart procedures. It's supplied as a 50 mg lyophilized powder for injection by Chiesi USA, Inc., and was approved by the FDA in 2015. This information was generated using AI and is provided for informational and research purposes only. --- ### 🔗 Related Datasets - Cangrelor — *HealthData.Gov* - Ticagrelor — *HealthData.Gov* - Ticagrelor — *HealthData.Gov* ---
Links
Get the data
- Cangrelor accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203308 ↗
download · from data virginia gov
Where it is published
- Virginia Open Data Portal dataset page data.virginia.gov/dataset/cangrelor ↗
landing page · from data virginia gov
Documentation and papers
- Publisher page fda.gov/drugs ↗
documentation · from data virginia gov
Catalogue records · 1
- CKAN API data.virginia.gov/api/3/action/package_show?id=e35d226f-8dcd-45f8-997c-c4391c7e5… ↗
metadata API · from data virginia gov
Topics
- Inferred from text
- Heart 75%
Provenance · 1 source records, 6 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| Virginia Open Data Portal | e35d226f-8dcd-45f8-997c-c4391c7e5691 | 5 h ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| concepts[anatomy].local:anatomy:heart | enrichment · data virginia gov | keyword-concept-rules@1.0.0 | title+description (75%) |
| created_date | source · data virginia gov | connector:data_virginia_gov@1.0.0 | |
| description | source · data virginia gov | connector:data_virginia_gov@1.0.0 | /notes |
| publication_date | source · data virginia gov | connector:data_virginia_gov@1.0.0 | |
| title | source · data virginia gov | connector:data_virginia_gov@1.0.0 | /title |
| updated_date | source · data virginia gov | connector:data_virginia_gov@1.0.0 |